[Renal lymphoma in a cat: diagnostics, therapy and survival time. A case report].
The clinical case report describes diagnostics, therapy, response and outcome in a 7-year-old castrated male European Shorthair cat with renal lymphoma. By use of a combination chemotherapy, partial remission was achieved 8 days after induction, with a complete remission after 72 days. During chemotherapy the cat had a good quality of life. Adverse effects were limited to two episodes of vomiting and one short period of slight depression. At 629 days after the end of the chemotherapy, following 1449 days in remission, a relapse of the renal lymphoma was diagnosed. During the second chemotherapy, extension of the lymphoma to the CNS became apparent and the cat was euthanized after an overall survival time of 1509 days (4 years). The case shows that treating renal lymphoma in cats by adequate combination chemotherapy can achieve long survival times with a good quality of life.
Klinik für Kleintiere, Stiftung Tierärztliche Hochschule Hannover, Bünteweg 9, 30559 Hannover. Stefanie.Schmidt@tiho-hannover.de
S
S
Schmidt
V
V
Nerschbach
N
N
Eberle
R
R
Mischke
I
I
Nolte
D
D
Betz
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002371:Cat Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D002415:Cats; D016543:Central Nervous System Neoplasms / Q000556:secondary / Q000662:veterinary; D037901:Euthanasia, Animal; D017809:Fatal Outcome; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*; D008223:Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000662:veterinary; D011788:Quality of Life; D012074:Remission Induction; D015996:Survival Rate